JP2022546424A5 - - Google Patents
Info
- Publication number
- JP2022546424A5 JP2022546424A5 JP2022513209A JP2022513209A JP2022546424A5 JP 2022546424 A5 JP2022546424 A5 JP 2022546424A5 JP 2022513209 A JP2022513209 A JP 2022513209A JP 2022513209 A JP2022513209 A JP 2022513209A JP 2022546424 A5 JP2022546424 A5 JP 2022546424A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- virus
- influenza
- inhibitor
- cap
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU101372 | 2019-08-27 | ||
| LULU101372 | 2019-08-27 | ||
| PCT/EP2020/073934 WO2021037956A1 (en) | 2019-08-27 | 2020-08-27 | Combinations of mek inhibitors with cap-dependent endonuclease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546424A JP2022546424A (ja) | 2022-11-04 |
| JP2022546424A5 true JP2022546424A5 (https=) | 2023-09-01 |
Family
ID=68234302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513209A Pending JP2022546424A (ja) | 2019-08-27 | 2020-08-27 | Ｍｅｋ阻害剤とキャップ依存性エンドヌクレアーゼ阻害剤との組み合わせ |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220370384A1 (https=) |
| EP (1) | EP4021435A1 (https=) |
| JP (1) | JP2022546424A (https=) |
| KR (1) | KR20220074869A (https=) |
| CN (1) | CN114667138A (https=) |
| AU (1) | AU2020338695A1 (https=) |
| BR (1) | BR112022003673A2 (https=) |
| CA (1) | CA3149588A1 (https=) |
| MX (1) | MX2022002413A (https=) |
| WO (1) | WO2021037956A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU101183B1 (en) * | 2019-04-16 | 2020-10-16 | Atriva Therapeutics Gmbh | Novel mek-inhibitor for the treatment of viral and bacterial infections |
| AU2021206684B2 (en) | 2020-01-10 | 2024-01-18 | Immuneering Corporation | MEK inhibitors and therapeutic uses thereof |
| WO2024042050A1 (en) * | 2022-08-22 | 2024-02-29 | Atriva Therapeutics Gmbh | Use of mek1/2 inhibitors to synergistically potentiate the antiviral effect of direct-acting anti-coronavirus drugs |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10017480A1 (de) * | 2000-04-07 | 2001-10-11 | Transmit Technologietransfer | Verwendung von Substanzen, die als MEK Inhibitor wirken, zur Herstellung eines Arneimittels gegen DNA- und RNA-Viren |
| DK2620436T3 (en) * | 2010-09-24 | 2018-07-30 | Shionogi & Co | Substituted polycyclic carbamoylpyridone derivative prodrug |
| WO2014056894A1 (en) | 2012-10-08 | 2014-04-17 | Westfaelische Wilhelms-Universitaet Muenster | Mek inhibitors in the treatment of virus diseases |
| CN113398271A (zh) | 2014-05-16 | 2021-09-17 | 归属疗法有限公司 | 抗流感病毒和金黄色葡萄球菌合并感染的新型抗感染策略 |
| KR20190018469A (ko) * | 2016-08-10 | 2019-02-22 | 시오노기세야쿠 가부시키가이샤 | 치환된 다환성 피리돈 유도체 및 그의 프로드러그를 함유하는 의약 조성물 |
| EP3973960B1 (en) | 2017-10-17 | 2025-09-03 | Atriva Therapeutics GmbH | Novel mek-inhibitor for the treatment of viral and bacterial infections |
| US20190298669A1 (en) * | 2018-03-29 | 2019-10-03 | Atriva Therapeutics Gmbh | Ci-1040 for the treatment of viral diseases |
-
2020
- 2020-08-27 KR KR1020227009384A patent/KR20220074869A/ko not_active Ceased
- 2020-08-27 WO PCT/EP2020/073934 patent/WO2021037956A1/en not_active Ceased
- 2020-08-27 EP EP20774883.1A patent/EP4021435A1/en not_active Withdrawn
- 2020-08-27 CA CA3149588A patent/CA3149588A1/en active Pending
- 2020-08-27 JP JP2022513209A patent/JP2022546424A/ja active Pending
- 2020-08-27 AU AU2020338695A patent/AU2020338695A1/en not_active Abandoned
- 2020-08-27 CN CN202080073758.1A patent/CN114667138A/zh active Pending
- 2020-08-27 BR BR112022003673A patent/BR112022003673A2/pt not_active Application Discontinuation
- 2020-08-27 US US17/638,440 patent/US20220370384A1/en not_active Abandoned
- 2020-08-27 MX MX2022002413A patent/MX2022002413A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015534562A5 (https=) | ||
| CN114786659B (zh) | 用于治疗汉坦病毒感染的mek抑制剂 | |
| JP2022551458A5 (https=) | ||
| JP2022546424A5 (https=) | ||
| DK1982708T3 (en) | Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanediol derivative as active ingredient and method of treating inflammatory bowel disease | |
| JP2018021051A5 (https=) | ||
| JP2020537659A5 (https=) | ||
| JP2019509276A5 (https=) | ||
| MX2022003984A (es) | Compuestos heterociclicos antivirales. | |
| JP2017525681A (ja) | パラミクソウイルスの治療方法 | |
| JP2013209405A5 (https=) | ||
| Tognotti | Influenza pandemics: a historical retrospect | |
| JP2025508656A5 (https=) | ||
| SI2760821T1 (en) | A salt salt of an anti-inflammatory substituted cyclobutenedione compound | |
| KR20180125552A (ko) | 바이러스 감염을 치료하기 위한 티아졸리드 화합물 | |
| UY40215A (es) | Compuestos heterocíclicos antivirales | |
| JP2023520323A5 (https=) | ||
| JP2025124703A (ja) | ウイルス感染および細菌感染の治療のための新規ｍｅｋ阻害剤 | |
| JP2020529995A5 (https=) | ||
| CA3175526A1 (en) | Pirfenidone for coronavirus treatment | |
| WO2021195521A1 (en) | Methods of treating coronavirus infections | |
| CL2022001317A1 (es) | Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma. | |
| CL2024001073A1 (es) | Inhibidores de la replicación del virus de inmunodeficiencia humana | |
| WO2022013324A3 (en) | Post-exposure vaccination against viral respiratory infections | |
| JP2022505183A5 (https=) |